<bill session="109" type="h" number="2299" updated="2019-11-15T21:18:34Z">
  <state datetime="2005-05-11">REFERRED</state>
  <status>
    <introduced datetime="2005-05-11"/>
  </status>
  <introduced datetime="2005-05-11"/>
  <titles>
    <title type="short" as="introduced">Generic Drugs Access Act of 2005</title>
    <title type="display">Generic Drugs Access Act of 2005</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to establish therapeutic equivalence requirements for generic drugs, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="P000034"/>
  <cosponsors/>
  <actions>
    <action datetime="2005-05-11">
      <text>Introduced in House</text>
    </action>
    <action datetime="2005-05-11" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2005-05-23">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative procedure"/>
    <term name="Communication in medicine"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug approvals"/>
    <term name="Federal preemption"/>
    <term name="Generic drugs"/>
    <term name="Government Operations and Politics"/>
    <term name="Government paperwork"/>
    <term name="Government publicity"/>
    <term name="Law"/>
    <term name="Local laws"/>
    <term name="State laws"/>
  </subjects>
  <amendments/>
  <summary date="2005-06-21T19:44:52Z" status="Introduced in House">Generic Drugs Access Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to include in an approval of an abbreviated application for a new drug a finding about whether the approved drug is the therapeutic equivalent of the previously approved or listed drug involved. Sets forth criteria for a drug to be established as therapeutically equivalent.

Prohibits a state or its political subdivision from establishing or continuing any requirement that does not conform to the therapeutic equivalence requirement of this Act.</summary>
</bill>
